[Prostate cancer with penile metastasis: a case report].
A 77-year-old man presented with complaints of dysuria, nocturia and painless nodule on his penis. Laboratory examination revealed elevated serum prostate-specific antigen (PSA) and CA19-9. Pathological examinations on prostate and penile biopsy specimens revealed prostate adenocarcinoma with penile metastasis. The patient was diagnosed as having prostate cancer stage D2 (T4N1M1) with bone, lymph node and penile metastases. There was no response to initial hormonal therapy with the surgical castration and diethylstilbestrol. However, decrease of the tumor size, as well as PSA and CA19-9 values were achieved after the combined chemotherapy with Estramustine, Paclitaxel and Carboplatin.
Sawada
Atsuro
A
The Department of Urology, Kyoto University, Faculty of the Medicine.
Segawa
Takehiko
T
Nakanishi
Shinichi
S
Kinoshita
Hidefumi
H
Yamamoto
Shingo
S
Kamoto
Toshiyuki
T
Ogawa
Osamu
O
D000230:Adenocarcinoma / Q000188:drug therapy / Q000556:secondary*; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D014408:Biomarkers, Tumor / Q000097:blood; D018395:CA-19-9 Antigen / Q000097:blood; D016190:Carboplatin / Q000008:administration & dosage; D003131:Combined Modality Therapy; D004961:Estramustine / Q000008:administration & dosage; D006801:Humans; D008297:Male; D009919:Orchiectomy; D017239:Paclitaxel / Q000008:administration & dosage; D010412:Penile Neoplasms / Q000188:drug therapy / Q000556:secondary*; D017430:Prostate-Specific Antigen / Q000097:blood; D011471:Prostatic Neoplasms / Q000188:drug therapy / Q000473:pathology*
D014408:Biomarkers, Tumor; D018395:CA-19-9 Antigen; D004961:Estramustine; D016190:Carboplatin; D017430:Prostate-Specific Antigen; D017239:Paclitaxel